Cite
Reports from Kangwon National University Highlight Recent Findings in COX-2 Inhibitors (Vismodegib Identified As a Novel Cox-2 Inhibitor Via Deep-learning-based Drug Repositioning and Molecular Docking Analysis).
MLA
“Reports from Kangwon National University Highlight Recent Findings in COX-2 Inhibitors (Vismodegib Identified As a Novel Cox-2 Inhibitor Via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis).” Medical Letter on the CDC & FDA, Oct. 2023, p. 1644. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=172944831&authtype=sso&custid=ns315887.
APA
Reports from Kangwon National University Highlight Recent Findings in COX-2 Inhibitors (Vismodegib Identified As a Novel Cox-2 Inhibitor Via Deep-learning-based Drug Repositioning and Molecular Docking Analysis). (2023). Medical Letter on the CDC & FDA, 1644.
Chicago
“Reports from Kangwon National University Highlight Recent Findings in COX-2 Inhibitors (Vismodegib Identified As a Novel Cox-2 Inhibitor Via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis).” 2023. Medical Letter on the CDC & FDA, October, 1644. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=172944831&authtype=sso&custid=ns315887.